HAOHAI BIOTEC Schedules 2025 AGM for 29 May 2026; Agenda Covers Profit Distribution, Director Elections and H-Share Buy-Back Mandate

Bulletin Express

Apr 28

Shanghai Haohai Biological Technology Co., Ltd. (HAOHAI BIOTEC) has issued its proxy form and notice for the 2025 Annual General Meeting, set for 2:00 p.m. on Friday, 29 May 2026 at 24/F, WenGuang Plaza, No. 1386 Hongqiao Road, Changning District, Shanghai. Key matters requiring shareholder approval are as follows:

1. Routine Business • Board Work Report for 2025 • 2025 Financial Report • 2025 Profit Distribution Plan and authorisation for the Board to declare 2026 interim dividends • Appointment of external auditors for the 2026 financial statements and internal controls

2. Remuneration and Governance • 2026 remuneration plan for directors • Updated Remuneration Management Policies covering directors and senior management

3. Board Composition • Election of Ms. Tian Min as an executive director • Election of three independent non-executive directors—Mr. Chan Sui Yu, Mr. Song Yuanyang and Ms. Xu Duoqi—via cumulative voting

4. Capital Management • Special resolution granting the Board a general mandate to repurchase H shares

Shareholders recorded in the H-share register may appoint proxies by submitting completed forms to the company’s registrar, Computershare Hong Kong Investor Services Limited, by 2:00 p.m. on 28 May 2026. Attendance in person remains an option, in which case previously lodged proxies will be deemed revoked.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1112898658"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1112898658\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1112898658?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-28 17:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1112898658","market":"us","top_or_hot":-1,"title":"HAOHAI BIOTEC Schedules 2025 AGM for 29 May 2026; Agenda Covers Profit Distribution, Director Elections and H-Share Buy-Back Mandate","media":"Bulletin Express","content":"<p>Shanghai Haohai Biological Technology Co., Ltd. (HAOHAI BIOTEC) has issued its proxy form and notice for the 2025 Annual General Meeting, set for 2:00 p.m. on Friday, 29 May 2026 at 24/F, WenGuang Plaza, No. 1386 Hongqiao Road, Changning District, Shanghai. Key matters requiring shareholder approval are as follows:</p>\n<p>1. Routine Business  \n   • Board Work Report for 2025  \n   • 2025 Financial Report  \n   • 2025 Profit Distribution Plan and authorisation for the Board to declare 2026 interim dividends  \n   • Appointment of external auditors for the 2026 financial statements and internal controls</p>\n<p>2. Remuneration and Governance  \n   • 2026 remuneration plan for directors  \n   • Updated Remuneration Management Policies covering directors and senior management</p>\n<p>3. Board Composition  \n   • Election of Ms. Tian Min as an executive director  \n   • Election of three independent non-executive directors—Mr. Chan Sui Yu, Mr. Song Yuanyang and Ms. Xu Duoqi—via cumulative voting</p>\n<p>4. Capital Management  \n   • Special resolution granting the Board a general mandate to repurchase H shares</p>\n<p>Shareholders recorded in the H-share register may appoint proxies by submitting completed forms to the company’s registrar, Computershare Hong Kong Investor Services Limited, by 2:00 p.m. on 28 May 2026. Attendance in person remains an option, in which case previously lodged proxies will be deemed revoked.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HAOHAI BIOTEC Schedules 2025 AGM for 29 May 2026; Agenda Covers Profit Distribution, Director Elections and H-Share Buy-Back Mandate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHAOHAI BIOTEC Schedules 2025 AGM for 29 May 2026; Agenda Covers Profit Distribution, Director Elections and H-Share Buy-Back Mandate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-28 17:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Haohai Biological Technology Co., Ltd. (HAOHAI BIOTEC) has issued its proxy form and notice for the 2025 Annual General Meeting, set for 2:00 p.m. on Friday, 29 May 2026 at 24/F, WenGuang Plaza, No. 1386 Hongqiao Road, Changning District, Shanghai. Key matters requiring shareholder approval are as follows:</p>\n<p>1. Routine Business  \n   • Board Work Report for 2025  \n   • 2025 Financial Report  \n   • 2025 Profit Distribution Plan and authorisation for the Board to declare 2026 interim dividends  \n   • Appointment of external auditors for the 2026 financial statements and internal controls</p>\n<p>2. Remuneration and Governance  \n   • 2026 remuneration plan for directors  \n   • Updated Remuneration Management Policies covering directors and senior management</p>\n<p>3. Board Composition  \n   • Election of Ms. Tian Min as an executive director  \n   • Election of three independent non-executive directors—Mr. Chan Sui Yu, Mr. Song Yuanyang and Ms. Xu Duoqi—via cumulative voting</p>\n<p>4. Capital Management  \n   • Special resolution granting the Board a general mandate to repurchase H shares</p>\n<p>Shareholders recorded in the H-share register may appoint proxies by submitting completed forms to the company’s registrar, Computershare Hong Kong Investor Services Limited, by 2:00 p.m. on 28 May 2026. Attendance in person remains an option, in which case previously lodged proxies will be deemed revoked.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06826","symbol_name":"昊海生物科技","start_time":0,"source_url":"","article_id":"1112898658","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1112898658","pubTimestamp":1777368359,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Haohai Biological Technology Co., Ltd. (HAOHAI BIOTEC) has issued its proxy form and notice for the 2025 Annual General Meeting, set for 2:00 p.m. on Friday, 29 May 2026 at 24/F, WenGuang...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06826":"昊海生物科技"},"translate_title":"昊海生物科技计划于2026年5月29日举行2025年年度股东大会；议程包括利润分配、董事选举及H股回购授权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06826":1},"content_text":"Shanghai Haohai Biological Technology Co., Ltd. (HAOHAI BIOTEC) has issued its proxy form and notice for the 2025 Annual General Meeting, set for 2:00 p.m. on Friday, 29 May 2026 at 24/F, WenGuang Plaza, No. 1386 Hongqiao Road, Changning District, Shanghai. Key matters requiring shareholder approval are as follows:\n1. Routine Business  \n   • Board Work Report for 2025  \n   • 2025 Financial Report  \n   • 2025 Profit Distribution Plan and authorisation for the Board to declare 2026 interim dividends  \n   • Appointment of external auditors for the 2026 financial statements and internal controls\n2. Remuneration and Governance  \n   • 2026 remuneration plan for directors  \n   • Updated Remuneration Management Policies covering directors and senior management\n3. Board Composition  \n   • Election of Ms. Tian Min as an executive director  \n   • Election of three independent non-executive directors—Mr. Chan Sui Yu, Mr. Song Yuanyang and Ms. Xu Duoqi—via cumulative voting\n4. Capital Management  \n   • Special resolution granting the Board a general mandate to repurchase H shares\nShareholders recorded in the H-share register may appoint proxies by submitting completed forms to the company’s registrar, Computershare Hong Kong Investor Services Limited, by 2:00 p.m. on 28 May 2026. Attendance in person remains an option, in which case previously lodged proxies will be deemed revoked.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}